心理一致感的潜结构研究

目的：探讨Antonovsky开发的13个项日的心理一致感量表在中国大陆的适用性。方法：采用实证研究方式对656名被试的样本数据进行了探索性及验证性因索分析，结果：个体的心理一致感是由可理解性、易处理性及意义性三个成分构成的总体．支持Antonovsky提出的关于心理一致感的要念构思。结论：心理一致感量表对中国大陆样本基本上是适用的，但个别题目有待进一步修正。     

强化膨胀式椎弓根螺钉翻修作用的生物力学评价

目的测试骨水泥强化膨胀式椎弓根螺钉(augmentation expansive pedicle screwfixa-tion with polymethyl methacrylate,AEPS),未强化的膨胀式椎弓根螺钉(expansive pedicle screw,EPS),CDH椎弓根螺钉翻修后的最大轴向拔出力,评价AEPS螺钉的翻修效应。方法24个新鲜小牛腰椎随机分成三组,AEPS组、EPS组、CDH组,每组8个椎体,三组椎体的椎弓根处均预先植入直径6.5mm CDH螺钉,拔出螺钉造成螺钉松动脱出的脊柱模型,然后分别植入AEPS、EPS、CDH螺钉,再次拔出螺钉,记录翻修后最大轴向拔出力。结果AEPS、EPS、CDH螺钉翻修后的最大拔出力分别为(2723.3±565.4)、(2216.3±475.6)和(1321.4±346.7)N,AEPS和EPS螺钉最大拔出力均显著高于CDH螺钉(P<0.05),AEPS轴向拔出力高于EPS螺钉,但差异无统计学意义(P>0.05)。结论AEPS与EPS螺钉具有相当的翻修作用。     

单人手法整复治疗儿童尺桡骨下段双骨折

儿童尺桡骨下段双骨折,临床以桡偏背侧重叠移位多见且整复难度较大,1999-2004年运用单人手法整复治疗32例,取得满意疗效,现报告如下。1临床资料本组32例,男28例,女4例;年龄2~14岁。均于伤后1h~3d内就诊。开放性2例,闭合性30例;左侧22例,右侧10例。尺桡骨骨折线距下端骨骺线1~3c     

加替沙星序贯治疗下呼吸道细菌感染的药物经济学评价

目的对加替沙星序贯治疗下呼吸道细菌感染进行药物经济学评价。方法将69例下呼吸道细菌性感染患者，随机分为A组（34例）、B组（35例），其中A组采用加替沙星注射液400mg静脉滴注，每天1次，连用10天；B组先用加替沙星注射液400mg静脉滴注，每天1次，3—4天后改为口服400mg，每天1次，连用6—7天，然后对两种方案进行成本-效果分析。结果两组在临床疗效、不良反应发生率及细菌清除率方面差异无统计学意义（P〉0．05）；但A组的医疗费用却高于B组（P〈0．01）。结论加替沙星序贯疗法与单纯静脉滴注相比更安全，更经济合理。     

社会主义本质论教学探讨

社会主义本质论本身比较抽象,加上现实与理论存在着较大差距,学生思想认识问题较多,使得社会主义本质论的教学难以得取得实效。针对这一实际,提出了从历史和现实2个方面激发学生的学习兴趣,用"定义法"和"比较法"讲清"什么是社会主义",从理论和实践两个层面解决学生思想认识问题的教学策略,为提高教学实效探索了一条有效途径。     

Scintigraphic evaluation of myocardial uptake of thallium 201 and technetium 99m pyrophosphate utilizing a rat model of chronic doxorubicin cardiotoxicity

To evaluate the usefulness of myocardial scintigraphy as a monitoring tool for chronic doxorubicin (DXR) cardiotoxicity, a rat model was used to investigate the relationship between the myocardial uptake of thallium 201 (Tl) or rechnetium 99m pyrophosphate (^99mTc-PPi) and histological changes of the heart. Although there was no significant difference in myocardial Tl uptake between control and DXR-treated rats at an early phase after Tl injection, late-phase Tl uptake was significantly higher in the DXR-treated rats than in the control rats, indicating a slow wash-out of Tl from the myocardium. The wash-out rate calculated from scintigraphic examination of DXR-treated rats was significantly decreased with increasing degree of cardiomyopathy. Since the Tl wash-out rate was sharply decreased even in animals with minimal histological changes, it may be a possible monitoring tool for the early detection of chronic DXR cardiotoxicity. On the other hand, myocardial^99mTc-PPi images could be obtained only in rats with severe myocardial changes and hence would not useful for early detection.     

趋化因子及其受体在肿瘤侵袭转移中的作用

近年来陆续发现了许多新的趋化因子和受体，研究发现趋化因子及其受体参与机体的多种生理和病理过程，并在肿瘤的侵袭转移中通过不同机制发挥着重要作用。本文对其进行简要综述。     

Establishing the Cost-Effectiveness of New Pharmaceuticals under Conditions of Uncertainty—When Is There Sufficient Evidence?

Decisions about which health-care interventions represent adequate value to collectively funded health-care systems are as widespread as they are unavoidable. In the case of new pharmaceuticals, many countries now require formal cost-effectiveness analysis to inform this decision-making process. This requires evidence on parameters associated with health-related utilities, treatment effects, resource use, and costs, for which data from available regulatory trials are invariably absent or highly uncertain. This uncertainty results from a number of factors including the predominance of intermediate end points in the clinical evidence-base and the limited period of follow-up of patients in clinical studies. Despite these imperfections in the evidence base, decisions about whether new pharmaceuticals are sufficiently cost-effective for reimbursement cannot be side-stepped. Data limitations do, however, require the use of rigorous analytical methods to support decision making. Probabilistic decision models and value of information analysis offer a means of structuring decision problems, synthesizing all available data, characterizing the uncertainty in the decision, quantifying the cost of uncertainty, and establishing the expected value of perfect information. This analytical framework is important because it addresses two fundamental questions about new pharmaceuticals. First, is the product expected to be cost-effective on the basis of existing evidence? Second, is additional research concerning the product itself cost-effective? In addressing these questions, the analytical framework can establish when sufficient evidence exists to sustain a claim for a new pharmaceutical to be cost-effective.     

Association analysis of genes in the renin‐angiotensin system with subclinical cardiovascular disease in families with Type 2 diabetes mellitus: The Diabetes Heart Study

Aims Cardiovascular disease (CVD) is a major complication of Type 2 diabetes mellitus. The renin‐angiotensin system (RAS) and nitric oxide production are both important regulators of vascular function and blood pressure. Genes encoding proteins involved in these pathways are candidates for a contribution to CVD in diabetic patients. We have investigated variants of the angiotensinogen (AGT), angiotensin converting enzyme (ACE), angiotensin type 1 receptor (AT1R) and endothelial nitric oxide synthase (NOS3) genes for association with subclinical measures of CVD in families with Type 2 diabetes mellitus (T2DM). Methods Atherosclerosis was measured by carotid intima‐media thickness and calcification of the carotid and coronary arteries in 620 European Americans and 117 African Americans in the Diabetes Heart Study. Because of the role of these systems in blood pressure regulation, blood pressure was also investigated. Results Compelling evidence of association was not detected with any of the SNPs with any outcome measures after adjustments for covariates despite sufficient power to detect relatively small differences in traits for specific genotype combinations. Conclusions Genetic variation of the RAS and NOS3 genes do not appear to strongly influence subclinical cardiovascular disease or blood pressure in this diabetic population.     

Development of the Qualeffo–31, an osteoporosis-specific quality-of-life questionnaire

Introduction Vertebral deformities are a common consequence of osteoporosis and are known to decrease quality of life. The Qualeffo–41 is a quality-of-life questionnaire especially developed for measuring quality of life in patients with vertebral deformities. It consists of 41 questions arranged in five domains: pain, physical function, social function, general health perception, and mental function. The objectives of this study were: (1) to develop a shorter version of the Qualeffo–41 by removing redundant questions; and (2) to investigate the scale characteristics, reliability, and validity of this shorter version. Methods The study was performed using data from the Qualeffo validation study and the Multiple Outcomes of Raloxifene Evaluation (MORE) study. The analyses were performed in patients with vertebral deformities (n=579). Factor analysis on polychoric correlations and an item response theory (IRT) model, i.e., the generalized partial credit model (GPCM), were used to create a shorter version of Qualeffo–41. Using GPCM, scoring weights were computed for all items. Results Three items were removed from the data set because of too many missing values. Factor analysis identified three instead of five domains: (1) pain, (2) physical function, and (3) mental function. Five items had factor loadings <0.4 and were not included in the GPCM. After excluding several items, the domains pain (four items), physical function (18 items), and mental function (nine items) showed a good, reasonable, and excellent fit, respectively. This indicates that the mental function domain and the pain domain are more unidimensional than the physical function domain. All three domains showed a very high correlation (r ≥0.95) with the corresponding domains of the Qualeffo–41. Conclusions Qualeffo–31 was developed, consisting of three domains with a reasonable to excellent fit to the GPCM. Although the fit to the GPCM supports the construct validity of the Qualeffo–31, validation in a new study should be performed before using it in practice.